Trial intelligence / Profile preview

Alfentanil dosing strategies in pediatric dental procedures under sevoflurane anesthesia

ChiCTR2100043320Phase 4Recruiting

Sponsor
The Affiliated Stomatological Hospital of Chongqing Medical University
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of alfentanil in Maxillofacial Disorders and Emergence agitation (EA) (4 arms), sponsored by The Affiliated Stomatological Hospital of Chongqing Medical University. Primary endpoints: Emergence agitation and Recovery time. Started Oct 2020; status: recruiting.

02

Drugs

alfentanil
03

Conditions

Maxillofacial DisordersEmergence agitation (EA)

Beyond the preview

Go deeper on ChiCTR2100043320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100043320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call